Novavax Inc (NASDAQ:NVAX)

17.27
Delayed Data
As of Dec 08
 +0.045 / +0.26%
Today’s Change
15.53
Today|||52-Week Range
236.50
-87.93%
Year-to-Date
Novavax (NVAX) Down 7.6% Since Last Earnings Report: Can It Rebound?
Dec 08 / Zacks.com - Paid Partner Content
Novavax (NVAX) Stock Nosedives 88% This Year: Here's Why
Nov 28 / Zacks.com - Paid Partner Content
3 Supercharged Growth Stocks With 393% to 1,153% Upside in 2023, According to Wall Street
Dec 06 / MotleyFool.com - Paid Partner Content
Is Novavax Stock a Buy Now?
Nov 26 / MotleyFool.com - Paid Partner Content
Novavax (NVAX) COVID Jab Gets Expanded Label in WHO's EUL
Nov 30 / Zacks.com - Paid Partner Content
3 Potentially Explosive Stocks to Buy Before 2023
Nov 26 / MotleyFool.com - Paid Partner Content
Do Options Traders Know Something About Novavax (NVAX) Stock We Don't?
Nov 30 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close17.23
Today’s open17.24
Day’s range16.40 - 17.81
Volume123,984
Average volume (3 months)5,167,575
Market cap$1.2B
Data as of 3:21pm ET, 12/08/2022

Growth & Valuation

Earnings growth (last year)-222.51%
Earnings growth (this year)+69.97%
Earnings growth (next 5 years)+58.18%
Revenue growth (last year)+141.02%
P/E ratioNM
Price/Sales9.29
Price/Book--

Competitors

----
ALLOAllogene Therapeutic...-0.05-0.55%
TVTXTravere Therapeutics...-0.33-1.65%
TWSTTwist Bioscience Cor...-2.19-7.69%
Data as of 3:21pm ET, 12/08/2022

Financials

Next reporting dateFebruary 27, 2023
EPS forecast (this quarter)-$1.10
Annual revenue (last year)$1.1B
Annual profit (last year)-$1.7B
Net profit margin-152.12%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Gaithersburg, Maryland

Forecasts